Akari Therapeutics ADR
(AKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,746 | 7,822 | 5,732 | 6,269 | 2,737 |
| Receivables | N/A | N/A | N/A | 2,903 | N/A |
| Other current assets | 1,679 | 2,117 | 713 | 1,461 | 2,354 |
| TOTAL | $14,426 | $9,939 | $6,445 | $10,632 | $5,091 |
| Non-Current Assets | |||||
| PPE Net | N/A | 2 | 5 | 8 | 12 |
| Intangibles | 27 | 28 | 0 | 29 | 31 |
| Other Non-Current Assets | 0 | 0 | 30 | 0 | 17 |
| TOTAL | $27 | $30 | $35 | $38 | $61 |
| Total Assets | $14,452 | $9,969 | $6,480 | $10,670 | $5,151 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,191 | 966 | 1,229 | 1,315 | 1,482 |
| Accrued Expenses | 1,941 | 2,631 | 4,229 | 3,035 | 2,671 |
| Other current liabilities | 6,981 | 4,556 | 1,015 | 3,069 | 2,371 |
| TOTAL | $11,113 | $8,153 | $6,472 | $7,419 | $6,523 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,113 | $8,153 | $6,472 | $7,419 | $6,523 |
| Shareholders' Equity | |||||
| Common Shares | 46,579 | 40,086 | 31,987 | 30,124 | 24,538 |
| Retained earnings | -155,611 | -147,295 | -165,199 | -136,031 | -133,466 |
| Other shareholders' equity | -618 | -572 | -349 | -402 | -405 |
| TOTAL | $3,339 | $1,816 | $8 | $3,251 | $-1,372 |
| Total Liabilities And Equity | $14,452 | $9,969 | $6,480 | $10,670 | $5,151 |